32
Participants
Start Date
January 31, 2012
Primary Completion Date
February 29, 2012
Study Completion Date
March 31, 2012
BAY98-7111
2 x Naproxen Sodium 220 mg / Diphenhydramine HCl 25 mg combination under fasting conditions
Naproxen Sodium (Aleve, BAYH6689)
2 x Naproxen Sodium 220 mg under fasting conditions
Diphenhydramine HCl
2 x Diphenhydramine HCl 25 mg under fasting conditions
BAY98-7111
2 x Naproxen Sodium 220 mg / Diphenhydramine HCl 25 mg combination under fed conditions
Hackensack
Lead Sponsor
Bayer
INDUSTRY